Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Lianhua Products Designated as Epidemic Prevention Supplies : 2022 CIFTIS 2022-09-07 20:15
GenFleet Therapeutics to Present Data from Phase I Trial of GFH018 Monotherapy at the 2022 European Society for Medical Oncology Annual Meeting 2022-09-07 19:00
Laekna Announces First Patient Dosed in South Korea in LAE201INT2101 Phase 1/2 Study 2022-09-06 17:02
Amcor reveals Lift-Off seed capital winners with investments that seek to "drive the revolution in packaging" 2022-09-06 16:10
Jacobio Receives CDE Approval for KRAS G12C Inhibitor JAB-218822's Phase II Pivotal Study in China 2022-09-06 15:20
Dizal Announces Sunvozertinib Meets Primary Endpoint in its First Pivotal Study in Platinum-Pretreated NSCLC Patients with EGFR Exon20ins Mutations at 2022 ESMO 2022-09-05 22:49
Dizal Announces Positive Phase I Clinical Trial Results for DZD1516 in Treating HER2 Breast Cancer at 2022 ESMO 2022-09-05 22:39
Recruitment opens for Phase II trial in prostate cancer with Cu-64 SAR-Bombesin in the US 2022-09-05 21:09
Lunit to Showcase 5 Abstracts at ESMO 2022 2022-09-05 21:00
Vernalis Research, a fully owned subsidiary of HitGen Inc., and Unison Medicines Inc. announce a research collaboration in the field of anti-infectives 2022-09-05 16:00
Simcere Pharmaceutical Announces Financial Results for 2022 H1: 27% Year-Over-Year Revenue Growth, with Innovative Drugs Accounting for 65.4% of Total Revenue 2022-09-05 13:09
Tamas Oravecz Ph.D. named SVP, CSO of the U.S. of Simcere Pharmaceutical Group 2022-09-05 13:08
Neukio Biotherapeutics completed Series A-1 financing, to accelerate discovery and development of next generation cell therapy products 2022-09-02 20:50
Jacobio Completes First Patient Dosage of CD73 mAb JAB-BX102 in China 2022-09-02 19:00
Jacobio Completes First Dose of IIa Clinical Trial of JAB-21822 on KRAS G12C and STK11 Co-mutation in China 2022-09-02 17:14
Bridge Biotherapeutics Presented Non-clinical Study Results for 2 IPF Candidates at the IPF Summit 2022 2022-09-02 09:41
Zhongchao Inc. Announces its New Strategy Extension Focusing on the Oncology and Other Major Disease Management 2022-09-01 19:30
AI Startup AESOP Raises $3M to Tackle Medical and Billing Errors 2022-09-01 00:00
WuXi Biologics Announces GMP Release of Its First North American Biomanufacturing Facility in Cranbury, New Jersey 2022-08-31 20:00
Licensing and Agency Agreement Signed between Beijing Minhai (Biokangtai) and Phil. Pharmawealth, Inc. 2022-08-31 17:05
1 113 114 115 116 117 432